secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
CIK:        0001335105
Form:       8-K
Filed at:   2025-03-11T23:59:59+00:00
Accession:  0001493152-25-009786
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Lixte terminates at-the-market equity facility with WallachBeth Capital; effective March 18, 2025
--------------------------------------------------------------------------------

- Notice of termination of Sales Agreement with WallachBeth Capital LLC given on March 7, 2025.
- Termination becomes effective ten days after notice, i.e., March 18, 2025.
- Company plans to explore alternatives to raise additional equity capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1335105/000149315225009786/0001493152-25-009786-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1335105/000149315225009786/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-009786

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer